Karine Kocharian: Advancing Hemophilia Care Equity at the 79th World Health Assembly
Karine Kocharian, Regional Manager for Europe and Central Asia at World Federation of Hemophilia, shared World Federation of Hemophilia’s post on LinkedIn:
“Stay tuned.
Due to delays in the WHA program proceedings, the discussion on the WHA resolution to advance health equity for people with Hemophilia and other Bleeding Disorders, which is scheduled under 79th World Health Assembly agenda item 12.1 on non-communicable diseases, is expected to take place on Thursday, 21st May.”
World Federation of Hemophilia shared a post on LinkedIn:
“Due to delays in the WHA program proceedings, the discussion on the WHA resolution to advance health equity for people with Hemophilia and other Bleeding Disorders, which is scheduled under 79th World Health Assembly agenda item 12.1 on non-communicable diseases, is expected to take place on Thursday, 21st May.
The WFH team is participating in WHA79 sessions on-site in Geneva and will continue to closely monitor and share updates on any new developments.
Stay tuned for the next WFH communication with the livestream link to follow WHA79 discussion on this resolution live.”
Stay updated with Hemostasis Today.
-
May 24, 2026, 03:32Isaac Okello: Africa CDC Launches Continental Framework for Sickle Cell Disease
-
May 24, 2026, 03:31Dima Shulkin: Emerging Biomarkers for Early Prediction of Sepsis-Induced Shock
-
May 24, 2026, 00:54Andreas Ejlegard: The Promise of Smarter Antithrombotic Therapy with Cereno Scientific
-
May 24, 2026, 00:43Patient Advocacy and Clinical Excellence United at the European Certificate in Clinical Haemostasis – EHC
-
May 24, 2026, 00:41Mass General Brigham Research: Advancing the Future of Gene and Cell Therapy
-
May 23, 2026, 16:55Rahul Bhargava: Ensure Equal Recognition of Clinical Haematologists in Blood Cancer Clinical Trials
-
May 23, 2026, 16:44Brian O Mahony: World Haemophilia Day Receives Global WHO Recognition
-
May 23, 2026, 16:44Yusuf Hameed: Gene Therapy Could Reduce Lifetime Treatment Burden in Hemophilia A
-
May 23, 2026, 16:43Chokri Ben Lamine: Pacritinib Is a Key JAK Inhibitor for Cytopenic Myelofibrosis